In order to explore the dependency of AML cells on the Jak/Stat pathway in the context of the PRLR, the PRLRint AML cell lines MonoMac-1 and the PRLRlow AML cell lines HL-60 were treated with specific Stat3 and Stat5 inhibitors. This evidence concerns the gene STAT5A and acute myeloid leukemia.